PDA's 5th Annual Global Conference on Pharmaceutical Microbiology Conference Brochure

- Download the Brochure
- Request a Mailed Hard-copy

Supported by:

Justify Your Attendance

With this justification letter, we've made it convenient for you to justify your investment to attend PDA's 5th Annual Global Conference on Pharmaceutical Microbiology.

Overview

PDA's 5th Annual Global Conference on Pharmaceutical Microbiology will bring together all levels of industry professionals to network and benefit from a program that demystifies the underlying science of microbiology and seeks to solve the problems that our industry faces on a daily basis. The comprehensive program agenda will include presentations from regulatory and industry representatives from around the world who will share recent case studies and current trends in the field of pharmaceutical microbiology.

During the conference, PDA will host an exhibition of leading bio/pharmaceutical companies who will showcase new technologies and trends for pharmaceutical microbiology strategies. The PDA Training and Research Institute (PDA TRI) will host five courses on October 28 to complement topics presented at this conference. Courses include:

• Mycoplasma Filtration
• Auditing for Microbiological Aspects of Pharmaceutical and Biopharmaceutical Manufacturing
• Rapid Microbiological Methods: Overview of Technologies, Validation Strategies, Regulatory Opportunities and Return on Investment – new course
• Validation of Microbiological Test Methods – new course
• Investigating Microbiological Failures

Learning Objectives

At the completion of this program, participants will be able to:

• Describe the role of microbiology in Quality by Design, including managing microbial risk, microbial contamination control and risk management in aseptic
  processing/manufacturing
• Identify current trends in environmental monitoring and the economic aspect of microbiology (“lean laboratories” and the Return on Investment for Rapid Microbiology Methods)
• Implement appropriate strategies for maintaining a non-sterile manufacturing environment (the importance of microbial identification, testing for and understanding
  the impact of objectionable organisms and resolving microbial challenges associated
  with non-sterile operations)
• Summarize new advances in rapid microbiological methods, microbial identification
  technologies, endotoxin testing and the use of statistics during data review and
  validation activities
• Explain the elements of a sterility test failure investigation
• Identify local regulatory and pharmacopeial expectations

Who Should Attend

Departments
Microbiology, Compliance, Engineering, Manufacturing, QA/QC, Development, Regulatory Affairs, Research and Development, Validation

Level of Expertise
Executives, Management, Scientists/Technicians

Job Function
Scientist/Technician, Research, Analyst, Bench personnel

Contact

Leon D. Lewis
Assistant Manager, Programs and Web Seminars
Tel: +1 (301) 656-5900 ext. 149
E-mail: lewis@pda.org